21
Participants
Start Date
August 31, 2010
Primary Completion Date
February 29, 2012
Study Completion Date
August 31, 2012
Ofatumumab/HDMP
"High dose methylprednisolone sodium succinate (HDMP) at 1gm/m2 daily as infusion for 3 consecutive days every cycle.~Ofatumumab 300mg administered Day1 of cycle 1 followed by 12 doses of 1000mg administered based on specific schedule.~Each patient will receive a maximum of 3 cycles (one cycle is 28 days)"
UC San Diego Moores Cancer Center, La Jolla
University of California San Diego, Moores Cancer Center, La Jolla
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Januario Castro, M.D.
OTHER